Skip to content

Clinical trials

Completed Phase 1/2 Sarcoma, Ewing trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Ewing Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20131
20172
20181
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Eisai Inc.1
Eli Lilly and Company1
Grupo Espanol de Investigacion en Sarcomas1
Hutchmed1
Institute of Mother and Child, Warsaw, Poland1
M.D. Anderson Cancer Center1
National Cancer Institute (NCI)1
Sarcoma Alliance for Research through Collaboration1
Sarcoma Oncology Research Center, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Ewing11
Sarcoma7
Osteosarcoma6
Rhabdomyosarcoma6
Neuroblastoma3
Bone Neoplasms2
Chondrosarcoma2
Histiocytoma, Malignant Fibrous2
Leiomyosarcoma2
Melanoma2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.